Tandem Diabetes Care, Inc.
NASDAQ:TNDMMedical - Devices
Healthcare
$16.80 +1.53%
+$0.24 today
- Market cap
- $1.17B
- Beta
- 1.57
- P/E (TTM)
- -11.3
- EPS (TTM)
- -$1.38
52W Low $9.98High $29.65
Volume 2.30M
Average 2.43M
Income Statement
Follow revenue through to earnings.
Revenue
$1.01B
FY 2025 · Annual
+7.9% YoYOperating Income
-$78.12M
FY 2025 · Annual
Net Income
-$204.71M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 702.8M | 801.22M | 747.72M | 940.2M | 1.01B |
| Cost of Revenue | 326.58M | 388.23M | 380.03M | 450.63M | 483.89M |
| Gross Profit | 376.22M | 412.99M | 367.69M | 489.57M | 530.85M |
| Gross Margin | 53.5% | 51.5% | 49.2% | 52.1% | 52.3% |
| Research & Development | 92.05M | 170.15M | 248.42M | 198.88M | 174.84M |
| Selling, General & Admin | 261.51M | 335.68M | 352.5M | 389.82M | 434.13M |
| Operating Expenses | 353.56M | 505.83M | 600.92M | 588.7M | 608.97M |
| Depreciation & Amortization | 13.85M | 14.33M | 15.72M | 158K | 17.67M |
| EBITDA | 34.06M | (74.21M) | (196.46M) | (99.13M) | (174.7M) |
| EBITDA Margin | 4.8% | -9.3% | -26.3% | -10.5% | -17.2% |
| Operating Income | 22.65M | (92.85M) | (233.23M) | (99.13M) | (78.12M) |
| Operating Margin | 3.2% | -11.6% | -31.2% | -10.5% | -7.7% |
| Interest Income | 674K | 6.06M | 22.86M | 17.99M | 9.09M |
| Interest Expense | 6.04M | 6.21M | 9.88M | 7.42M | 7.91M |
| Other Income / Expenses | (6.75M) | (4K) | 12.98M | 7.26M | (122.15M) |
| Income Before Tax | 15.9M | (92.85M) | (220.25M) | (91.87M) | (200.27M) |
| Pre-Tax Margin | 2.3% | -11.6% | -29.5% | -9.8% | -19.7% |
| Income Tax Expense | 335K | 1.74M | 2.36M | 4.16M | 4.44M |
| Net Income | 15.57M | (94.59M) | (222.61M) | (96.03M) | (204.71M) |
| Net Margin | 2.2% | -11.8% | -29.8% | -10.2% | -20.2% |
| EPS (Basic) | 0.25 | (1.47) | (3.43) | (1.47) | (3.04) |
| EPS (Diluted) | 0.24 | (1.47) | (3.43) | (1.47) | (3.04) |
| 63M | 64.15M | 64.9M | 65.45M | 67.29M | |
| 64.35M | 64.15M | 64.97M | 65.45M | 67.29M |
TNDM Earnings Waterfall · TTM
NASDAQ:TNDM · Revenue to Net Income
Key Ratios
EPS$-1.40
Gross Margin54.8%
Net Margin-9.7%
P/E Ratio-166.6
P/S Ratio4.7
Analysis
$1.0B of revenue converted into -$94.5M of net income for the selected period. Gross margin is 54.8% and net margin is -9.7%, showing how much revenue survives after costs and taxes. EPS is $-1.40, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 13, 2026 | |
| SC 13G | SC 13G filing | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 29, 2026 |
How much revenue does TNDM generate?
Tandem Diabetes Care, Inc. (TNDM) reported $1.01B of revenue in fiscal 2025.
Is TNDM profitable?
Tandem Diabetes Care, Inc. (TNDM) reported -$204.71M of net income, with a net margin of -20.2%.
Continue the stock analysis
Jump to another research area for this company.